The Rb/E2F pathway and cancer

Human Molecular Genetics

Volumn 10, Issue 7, 2001, Pages 699-703

  Nevins, J R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; DNA; PROTEIN P16; PROTEIN P19; PROTEIN P53; PROTEIN P73; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CANCER; CELL CYCLE S PHASE; CELL FATE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DEREGULATION; DNA REPLICATION; DRUG TARGETING; GENE AMPLIFICATION; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOSS; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; TRANSACTIVATION;

ANIMALIA;

EID: 0035063183     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.7.699     Document Type: Review

References (57)

1. Mutation and cancer: Statistical study of retinoblastoma
2. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
3. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
4. The E2F transcription factor is a cellular target for the RB protein
5. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product
6. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor
7. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity
8. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
9. ink4 requires functional retinoblastoma protein
10. G1 phase progression: Cycling on cue
11. Toward an understanding of the functional complexity of the E2F and Retinoblastoma families
12. The regulation of E2F by pRB-family proteins
13. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase
14. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
15. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
16. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
17. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
18. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
19. P53 and E2F-1 cooperate to mediate apoptosis
20. E2F1-specific induction of apoptosis and p53 accumulation is modulated by mdm2
21. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rbl(+/-) mice
22. E2F-1 functions in mice to promote apoptosis and suppress proliferation
23. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection
24. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
25. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
26. ARF promotes MDm2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways
27. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
28. Mdm2 promotes the rapid degradation of p53
29. Regulation of p53 stability by Mdm2
30. Distinct roles for E2F proteins in cell growth control and apoptosis
31. ARF links the tumour suppressors RB and p53
32. Role for the p53 homologue p73 in E2F-1-induced apoptosis
33. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
34. Oncoprotein networks
35. Cancer cell cycles
36. The retinoblastoma protein and cell cycle control
37. Tumor induction and tissue atrophy in mice lacking E2F-1
38. Genomic structure and mutation screening of the E2F4 gene in human tumors
39. Various AGC repeat numbers in the coding region of the human transcription factor gene E2F-4
40. Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors
41. Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability
42. A cell cycle regulator potentially involved in genesis of many tumor types
43. Role of the retinoblastoma protein in the pathogenesis of human cancer
44. Molecular determinants of dysplasia in colorectal lesions
45. Activation but not inactivation of the MTS1 gene is associated with primary colorectal carcinomas
46. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
47. Identification of CDK4 as a target of c-MYC
48. Identification of c-Myc as a target of the APC pathway
49. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals
50. Complex transcriptional regulatory mechanisms control expression of the E2F3 locus
51. Developmental basis of retinal-specific induction of cancer by RB mutation
52. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation
53. Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma
54. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer
55. E2f3 is critical for normal cellular proliferation
56. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages
57. Integrating genetic approaches into the discovery of anticancer drugs